Acadia Healthcare (ACHC) Scheduled to Post Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) is set to issue its quarterly earnings data after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of $0.90 per share for the quarter. Acadia Healthcare has set its FY24 guidance at $3.45-3.65 EPS and its FY 2024 guidance at 3.450-3.650 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The company had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.92 earnings per share. On average, analysts expect Acadia Healthcare to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Acadia Healthcare Trading Down 0.6 %

Shares of ACHC stock opened at $50.89 on Monday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $4.72 billion, a P/E ratio of -363.50, a P/E/G ratio of 1.57 and a beta of 1.29. Acadia Healthcare has a twelve month low of $50.20 and a twelve month high of $87.77. The stock’s fifty day simple moving average is $68.58 and its 200 day simple moving average is $68.61.

Analysts Set New Price Targets

Several analysts recently commented on ACHC shares. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft upped their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, Barclays lowered their price objective on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and an average target price of $86.67.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.